Sage Otolaryngology

OTO: Corticosteroid Use in Otolaryngology: Current Considerations During the COVID-19 Era

Informações:

Sinopse

This podcast highlights original research published in the November official journal of the American Academy of Otolaryngology—Head and Neck Surgery (AAO-HNS) Foundation. The objectives were to offer pragmatic, evidence-informed advice on administering corticosteroids in otolaryngology during the coronavirus disease 2019 (COVID-19) pandemic, considering therapeutic efficacy, potential adverse effects, susceptibility to COVID-19, and potential effects on efficacy of vaccination against SARS-CoV-2, which causes COVID-19.   In conclusion, systemic corticosteroids (SCSs) reduce long-term morbidity in individuals with SSNHL and Bell’s palsy, reduce acute laryngotracheal edema, and have benefit in perioperative management for some procedures. Topical or locally injected corticosteroids are preferable for most other otolaryngologic indications. SCSs have not shown long-term benefit for sinonasal disorders. SCSs are not a contraindication to vaccination with COVID-19 vaccines approved by the US Food and Drug Administ